#LCSM Chat Topic 05/09/2019: What’s new in early stage lung cancer

Our May 9, 2019 #LCSM Chat at 8 pm Eastern (5 pm Pacific) will focus on the newest treatments for early stage lung cancer. The topic should be interesting to all who deal with early stage disease — patients, caregivers, oncology nurses, surgeons, radiologists, pulmonologists, pathologists, and oncologists. Although we have all heard about the tremendous advances in the treatment of metastatic lung cancer, we sometimes don’t appreciate the incredible progress we have also made in diagnosing and treating early stage lung cancer. Early stage patients can realistically strive for and expect… Read More

#LCSM Chat Topic 2019-02-07: Is it worth the drive?

Unfortunately, you just got diagnosed with cancer.  You and your family are desperately trying to figure out where to go and which doctor to see.  But how far are you willing to go?  Can you be more confident in your diagnosis, decrease your complications, and improve your chances of survival if you drive a little farther, past your local hospital, to a specialized center that treats a higher volume of cancer patients?  What would it take for you, the patient, to go that extra distance? Seminal surgical studies have described a “volume… Read More

#LCSM Chat Topic 5/3/18:  What Defines a “Quality” #LungCancer Treatment Center?  Thoughts from the Frontline

Our topic for the #LCSM Tweet Chat on Thursday, May 3rd (5 PM Pacific/8 PM Eastern) is “What Defines a “Quality” #LungCancer Treatment Center?  Thoughts from the Frontline.” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD). Recently the Centers for Medicaid and Medicare Services (CMS) announced it would cover next-generation sequencing (NGS) for US patients with stage III or IV lung cancer when ordered by a physician and performed in a CLIA-certified laboratory.  This decision makes broad genomic testing to available to many more patients.  Having increased access to… Read More